BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Park JY, Helm J, Coppola D, Kim D, Malafa M, Kim SJ. MicroRNAs in pancreatic ductal adenocarcinoma. World J Gastroenterol 2011; 17(7): 817-827 [PMID: 21412491 DOI: 10.3748/wjg.v17.i7.817]
URL: https://www.wjgnet.com/1007-9327/full/v17/i7/817.htm
Number Citing Articles
1
Brittany Silverman, Jiaqi Shi. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical ImplicationsInternational Journal of Molecular Sciences 2016; 17(12): 2138 doi: 10.3390/ijms17122138
2
Rajesh Singh, James W. Lillard, Shailesh Singh. Epigenetic Advancements in Cancer2016; : 27 doi: 10.1007/978-3-319-24951-3_2
3
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, Reza Ghanbari, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Pauli Puolakkainen, Sakari Knuutila. Oncogenomic Changes in Pancreatic Cancer and Their Detection in StoolBiomolecules 2022; 12(5): 652 doi: 10.3390/biom12050652
4
Ibrahim Reyaz, Bilal Khan, Neha James, Hammad Azhar, Abdur Rehman, Muhammad Waqas Younas, Hamza Rashid, Faisal F Al-Shaikhly, Mazin M Almomani, Mohammed Khaleel I. KH. Almadhoun, Noor Abdullah Yahya, Syed Faqeer Hussain Bokhari, Ahsan Shehzad. Emerging Horizons in the Diagnosis of Pancreatic Cancer: The Role of Circulating microRNAs as Early Detection Biomarkers for Pancreatic Ductal AdenocarcinomaCureus 2024;  doi: 10.7759/cureus.53023
5
Shiquan Li, Guoqiang Yan, Meng Yue, Zhenhua Kang, Lei Wang. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1Molecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.9770
6
Fiona O’Neill, Taylor-Jade Allen-Coyle, Sandra Roche, Justine Meiller, Neil T. Conlon, Niall Swan, Robert M. Straubinger, Justin Geoghegan, Ninfa L. Straubinger, Kevin Conlon, Ray McDermott, Finbarr O’Sullivan, Michael Henry, Paula Meleady, Gerard McVey, Robert O’Connor, Michael Moriarty, Martin Clynes. Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These TumorsLife 2023; 13(3): 608 doi: 10.3390/life13030608
7
Eeva M. Laurila, Saana Sandström, Laura M. Rantanen, Reija Autio, Anne Kallioniemi. Both inhibition and enhanced expression of miR‐31 lead to reduced migration and invasion of pancreatic cancer cellsGenes, Chromosomes and Cancer 2012; 51(6): 557 doi: 10.1002/gcc.21941
8
Andee Weisbeck, Rick Jansen. Nutrients and the Pancreas: An Epigenetic PerspectiveNutrients 2017; 9(3): 283 doi: 10.3390/nu9030283
9
Yue Xue, Ahmad N. Abou Tayoun, Kristine M. Abo, J. Marc Pipas, Stuart R. Gordon, Timothy B. Gardner, Richard J. Barth, Arief A. Suriawinata, Gregory J. Tsongalis. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasmCancer Genetics 2013; 206(6): 217 doi: 10.1016/j.cancergen.2013.05.020
10
Evans Quilichini, Cécile Haumaitre. Implication of epigenetics in pancreas development and diseaseBest Practice & Research Clinical Endocrinology & Metabolism 2015; 29(6): 883 doi: 10.1016/j.beem.2015.10.010
11
Irfana Muqbil, Fazlul H. Sarkar, Ramzi M. Mohammad, Asfar S. Azmi. Epigenetics and Cancer2013; : 1 doi: 10.1007/978-94-007-6612-9_1
12
Mike Mattie, Ashley Christensen, Mi Sook Chang, William Yeh, Suzanne Said, Yuriy Shostak, Linnette Capo, Alla Verlinsky, Zili An, Ingrid Joseph, Yi Zhang, Sathish Kumar-Ganesan, Karen Morrison, David Stover, Pia Challita-Eid. Molecular Characterization of Patient-Derived Human Pancreatic Tumor Xenograft Models for Preclinical and Translational Development of Cancer TherapeuticsNeoplasia 2013; 15(10): 1138 doi: 10.1593/neo.13922
13
Robert S. Edinger, Claudia Coronnello, Andrew J. Bodnar, William A. LaFramboise, Panayiotis V. Benos, Jacqueline Ho, John P. Johnson, Michael B. Butterworth. Aldosterone Regulates MicroRNAs in the Cortical Collecting Duct to Alter Sodium TransportJournal of the American Society of Nephrology 2014; 25(11): 2445 doi: 10.1681/ASN.2013090931
14
Jinping Jia, Hemang Parikh, Wenming Xiao, Jason W Hoskins, Holger Pflicke, Xuelu Liu, Irene Collins, Weiyin Zhou, Zhaoming Wang, John Powell, Snorri S Thorgeirsson, Udo Rudloff, Gloria M Petersen, Laufey T Amundadottir. An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancerBMC Medical Genomics 2013; 6(1) doi: 10.1186/1755-8794-6-33
15
Lulu Farhana, Marcia I. Dawson, Farhan Murshed, Jayanta K. Das, Arun K. Rishi, Joseph A. Fontana, Jörg D. Hoheisel. Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1RPLoS ONE 2013; 8(5): e61015 doi: 10.1371/journal.pone.0061015
16
Javier Martinez-Useros, Mario Martin-Galan, Maria Florez-Cespedes, Jesus Garcia-Foncillas. Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and TreatmentsCancers 2021; 13(13): 3209 doi: 10.3390/cancers13133209
17
SHIDUO SONG, JIAN ZHOU, SONGBING HE, DONGMING ZHU, ZIXIANG ZHANG, HUA ZHAO, YI WANG, DECHUN LI. Expression levels of microRNA-375 in pancreatic cancerBiomedical Reports 2013; 1(3): 393 doi: 10.3892/br.2013.88
18
Lulu Farhana, Marcia I Dawson, Joseph A Fontana. Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cellsCancer Biology & Therapy 2015; 16(1): 115 doi: 10.4161/15384047.2014.987070
19
Satyanarayana Rachagani, Muzafar A. Macha, Melanie S. Menning, Parama Dey, Priya Pai, Lynette M. Smith, Yin-Yuan Mo, Surinder K. Batra. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) modelOncotarget 2015; 6(37): 40295 doi: 10.18632/oncotarget.5641
20
Neveen Abd El Moneim Hussein, Zenat A. El Kholy, Medhat M. Anwar, Mohamed A. Ahmad, Shaymaa M. Ahmad. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancerJournal of Cancer Research and Clinical Oncology 2017; 143(1): 83 doi: 10.1007/s00432-016-2248-7
21
Khanmi Kasomva, Arnab Sen, Michael Gabriel Paulraj, Stephen Sailo, Vandana Raphael, Kekungu-u Puro, Shiwoto Ruth Assumi, Savarimuthu Ignacimuthu. Roles of microRNA in prostate cancer cell metabolismThe International Journal of Biochemistry & Cell Biology 2018; 102: 109 doi: 10.1016/j.biocel.2018.07.003
22
Marta Herreros-Villanueva, Meritxel Gironella, Antoni Castells, Luis Bujanda. Molecular markers in pancreatic cancer diagnosisClinica Chimica Acta 2013; 418: 22 doi: 10.1016/j.cca.2012.12.025
23
Nicola Gaianigo, Davide Melisi, Carmine Carbone. EMT and Treatment Resistance in Pancreatic CancerCancers 2017; 9(9): 122 doi: 10.3390/cancers9090122
24
Aristomenis-Dimitrios Tourvas, Constantinos C. Frangos. Towards an extension of the two-variable model of carcinogenesis through oncogenes and tumour suppressor genesMedical Hypotheses 2011; 77(6): 956 doi: 10.1016/j.mehy.2011.08.017
25
Zhao-Chun Chi. Research status and prgoress of nonalcoholic fatty pancreatic diseaseWorld Chinese Journal of Digestology 2020; 28(19): 933 doi: 10.11569/wcjd.v28.i19.933
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
26
CHUANLI REN, HUI CHEN, CHONGXU HAN, DAXIN WANG, DEYUAN FU. Increased plasma microRNA and CD133/CK18-positive cancer cells in the pleural fluid of a pancreatic cancer patient with liver and pleural metastases and correlation with chemoresistanceOncology Letters 2012; 4(4): 691 doi: 10.3892/ol.2012.798
27
P.W. Stather, J.B. Wild, N. Sylvius, E. Choke, R.D. Sayers, M.J. Bown. MicroRNAs associated with the pathways involved in the pathogenesis of abdominal aortic aneurysmsArtery Research 2012; 7(1): 28 doi: 10.1016/j.artres.2012.09.005
28
RAMADEVI SUBRAMANI, LAXMAN GANGWANI, SUSHMITA BOSE NANDY, ARUNKUMAR ARUMUGAM, MUNMUN CHATTOPADHYAY, RAJKUMAR LAKSHMANASWAMY. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)International Journal of Oncology 2015; 47(4): 1203 doi: 10.3892/ijo.2015.3129